Long-Term Cytokine Alterations Following Allogeneic Blood Transfusion

Journal of Investigative Medicine

Volumn 46, Issue 4, 1998, Pages 161-167

  Shao, Weiru ^a   Edelman, Linda S ^a   Sullivan, Dennis J ^a   Nelson, Edward W ^a   Shelby, Jane ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Blood transfusion; Cytokines; Kinetics; Murine

Indexed keywords

MURINAE;

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD TRANSFUSION; C3H MOUSE; MALE; MOUSE;

ANIMALS; BLOOD TRANSFUSION; CYTOKINES; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H;

EID: 0032037083     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusion on subsequent kidney transplants. Transplant Proc 1973;5(1):253-9.
2. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications following colorectal cancer operations. Am J Surg 1986;152:476-82.
3. Blumberg N, Heal JM. Perioperative blood transfusion and solid tumor recurrence. Cancer Invest 1987;5:615-25.
4. Triulzi DJ, Blumberg N, Heal JM. Association of transfusion with postoperative bacterial infection. Crit Rev Clin Lab Sci 1990;28(2):95-107.
5. Scorza LB, Waymack JP, Pruitt BA Jr. The effect of transfusions on the incidence of bacterial infection. Mil Med 1990;155:337-9.
6. Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. Br Med J 1985;390:1037-9.
7. Tartter PI, Burrows L, Papatestas AE, Lesnick G, Aufses AH Jr. Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 1985;97:225-9.
8. Peters WR, Fry RD, Fleshman JW, Kodner, IJ. Multiple blood transfusions reduce the recurrence rate of Crohn disease. Dis Colon Rectum 1989;32(9):749-53.
9. Waymack JP, Robb, E, Alexander, JW. Effect of transfusion on immune function in a traumatized animal model. Arch Surg 1987;122:935-9.
10. Winslow, GA, Shelby J, Nelson EW, Saffle JR. Influence of allogeneic blood transfusion on natural killer cell activity in burn injured mice. J Burn Care Rehabil 1996;17:117-23.
11. Nichols RL, Smith JW, Klein DB, Trunkey DD, Cooper RH, Adinolfi MF, Mills J. Risk of infection after penetrating abdominal trauma. NEJM 1984;311:(17)1065-70.
12. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 1996;40(4):501-12.
13. Jensen LS, Andersen AJ, Christiansen PM, Hokland, P, Juhl, CO, Madsen G, Mortensen J, Moller-Nielsen C, Hanberg-Sorensen F, Hokland M. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-16.
14. Drost AC, Burleson DG, Cioffi WG Jr, Jordan BS, Mason AD, Jr, Pruitt BA Jr. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 1993;35:335-9.
15. Collins JA. Recent developments in the area of massive transfusion. World J Surg 1987;11:75-81.
16. Stephan RN, Kisala JM, Dean RE, Geha AS, Chaudry IH. Effect of blood transfusion on antigen presentation function and on interleukin-2 generation. Arch Surg 1988;123:235-40.
17. Sullivan DJ, Barton RG, Edelman LS, Shao Y, Nelson EW, Shelby J. Distinct effects of allogeneic blood transfusion on splenocyte cytokine production after hemorrhagic shock. J Surg Res. In press.
18. Yago H, Yoshii H, Naiki M, Suehiro S. Stress and murine NK cell function: the role of blood loss. J Clin Lab Immunol 1992;37:123-32.
19. Shelby J, Fick J, Kolegraff RJ, Wakely E, Corry RJ. Prolonged heart allograft survival induced by massive preoperative blood transfusions. Transplantation 1985;40:113-6.
20. Shelby J, Marushack MM, Nelson EW. Prostaglandin production and suppresser cell induction in transfusion-induced immune suppression. Transplantation 1987;43(1):113-6.
21. Tartter PI. Experimental studies of blood transfusion and tumor growth. In: Tartter PI. Immunologic aspects of blood transfusion. Austin: R. G. Landes. 1992:47-53.
22. Shelby J. The role of eicosanoids in the transfusion effect. Transplant Proc 1988;20(6):1217-18.
23. Shelby J, Hisatake, G. Effect of ibuprophen and interleukin-2 on transfusion-induced suppression of cell mediated immunity. Arch Surg 1988;123:1397-99.
24. Kalechman Y, Gafter U, Sobelman D, Sredni B. The effect of a single whole-blood transfusion on cytokine secretion. J Clin Immunol 1990;10(2):99-105.
25. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppresser lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64(1):308-10.
26. Cué JI, Peyton JC, Malangoni MA. Does blood transfusion or hemorrhagic shock induce immunosuppression? J Trauma 1992;32(5):613-7.
27. Tietze M, Klüter H, Troch M, Kirchner. H. Immune responsiveness in orthopedic surgery patients after transfusion of autologous or allogeneic blood. Transfusion 1995;35(5):378-83.
28. + cells are responsible for the rapid elimination of allogeneic donor lymphoid cells. J Immunol 1996;157:4805-10.
29. Brown, RB. Serum iron and infection. Inf Dis Pract 1994;18(7):49-52.
30. Damas, P, Ledoux, D, Nys, M, Vrindts, Y, De Groote, D, Franchimont, P, Lamy, M. Cytokine serum level during severe sepsis in human IL-6 as a marker of seventy. Ann Surg 1992;215(4):356-62.
31. Kushner, I. Regulation of the acute phase response by cytokines. Perspect Biol Med 1993;36(4):611-22.
32. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cells. IV. Th2 clones secrete a factor that inhibits production by ThI clones. J Exp Med 1989;170:2081-95.
33. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 1996;40(4):613-7.
34. Merchant A, Deviere J, Byl B, De Groote D, Vincent J-L, Goldman M. Interleukin-10 production during septicemia. Lancet 1994;343:707-8.
35. Ertel W, Morrison MH, Ayala A, Dean RE, Chaudry IH. Interferon-γ attenuates hemorrhage induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery 1992;111(2):177-82.
36. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996;20(4):454-59.
37. Polk HC, Jr, Cheadle WG, Livingston DH, Rodriguez JL, Starko, KM, Izu AE, Jaffe HS, Sonnenfeld G. A randomized prospective clinical trial to determine the efficacy of interferon-γ in severely injured patients. Am J Surgery 1992;163:191-6.
38. Dries DJ, Jurkovich GJ, Maier RV, Clemmer TP, Struve SN, Weigelt JA, Stanford GG, Herr DL, Champion HR, Lewis FR. Effect of interferon gamma on infection related death in patients with severe injuries. Arch Surg 1994;129:1031-41.
39. Mock CN, Dries DJ, Jurkovich GJ, Maier RV. Assessement of two clinical trials: interferon-gamma therapy in severe injury. Shock 1996;5(4): 235-40.
40. Pirenne J, Benedetti E, Dunn DL. Graft versus host response: clinical and biological relevance after transplantation of solid organs. Transplantation Rev 1996:10(1):46-68.
41. Brennan DC, Mohanakumar T, Flye MW. Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms Am J Kidney Dis 1995; 26(5);701-15.